ALDX

ALDEYRA THERAPEUTICS INC

ALDX·01438T106·US·Common Stock·Healthcare - Biotechnology-13D/G

ALDX (ALDEYRA THERAPEUTICS INC) is held by 70 institutional investors as of Q2 2026. Largest holders: AQR CAPITAL MANAGEMENT LLC ($8M), VANGUARD CAPITAL MANAGEMENT LLC ($5M), D. E. Shaw & Co., Inc. ($4.1M). Net institutional sentiment: Mixed.

70
Holders
(6 Elite)
$50M
Total Value
38% (86)
Consensus
33 buying - 53 selling
13F: Insider & Congress: Updated regularly
ALDX

Smart Money Verdict

View all
Loading verdict
Held by 70 funds
6 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Jun 5, 2026 · Activists Aug 12, 2026 · Congress none

ActivistAQR Capital Management, LLCAQR Capital Management, LLC6.2%Aug 12, 2026
ActivistBlackRock, Inc.BlackRock, Inc.1.7%Jul 27, 2026
InsiderBCBrady Todd CBuy $418KJun 3, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
3.8M(+32.6%)$8M0.0%-72.29%
35
Decreased
2.4M(-0.1%)$5M0.0%-56.39%
0
Increased
1.9M(+38.2%)$4.1M0.0%-81.75%
35
Increased
1.5M(+1062.0%)$3.2M0.0%-64.77%
43
Increased
1.4M(+41.9%)$2.9M0.0%-72.04%
35
Decreased
1.3M(-66.6%)$2.7M0.0%-86.19%
0
Increased
1.1M(+1196.3%)$2.4M0.0%-68.75%
42
Increased
882,000(+2.2%)$1.9M0.0%-75.27%
26
Decreased
794,863(-1.6%)$1.7M0.0%-56.39%
0
Increased
725,444(+33.6%)$1.5M0.0%-78.94%
33
Decreased
646,840(-18.8%)$1.4M0.0%-83.19%
0
Increased
608,321(+17.3%)$1.3M0.0%-81.99%
30
Decreased
596,029(-52.4%)$1.3M0.0%-90.39%
0
Decreased
529,083(-15.2%)$1.1M0.0%-87.89%
0
New
421,178$897,1090.0%-65.40%
34
Increased
379,144(+42.4%)$807,5760.0%-59.53%
33
Decreased
360,350(-63.8%)$767,5460.0%-60.05%
0
Decreased
301,940(-43.8%)$643,1320.0%-68.82%
0
Decreased
298,242(-11.9%)$635,2550.0%-56.39%
0
Increased
254,777(+238.9%)$542,6750.0%-71.48%
39

Showing 1-20 of 91

1 / 5
ALDXALDXALDEYRA THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used